AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 378017
Drug: Atropine (0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (0.01 mg/kg)
Trial: 18780503
Drug: Scopolamine (0.006
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine (0.006 mg/kg)
Trial: 16038528
Drug: Midazolam +
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam + chemotherapy
Trial: 16038528
Drug: Propofol +
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol + chemotherapy
Trial: 16038528
Drug: Midazolam +
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam + chemotherapy and Propofol + chemotherapy
Trial: 1823965
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy based on melphalan
Trial: 1823965
Drug: Chemotherapy supported
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy supported by immunomodulatory agents (calf thymus extract, levamisole, interferon)
Trial: 8980592
Drug: Chloroquine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine (25 mg/kg over three days)
Trial: 7036438
Drug: Fansidar (35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fansidar (35 mg sulphadoxin (+ 1/20 pyrimethamine) per kg single dose)
Trial: 30982782
Drug: Acupressure applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acupressure applied to acupuncture points (PC‐6, HT‐7, CV‐17), twice per day (2-4 sessions)
Trial: 26799154
Drug: Implant-assisted mandibular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implant-assisted mandibular removable partial dentures
Trial: 23390192
Drug: EPA (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA (1000 mg EPA:200 mg DHA)
Trial: 23390192
Drug: DHA (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA (200 mg EPA:1000 mg DHA)
Trial: 12716332
Drug: Powered toothbrush
RxNorm normalized name: Pro Clean Spinbrush Powered Toothbrush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powered toothbrush (PTB) with brushing force of 75 g for 30, 60, 120, and 180 seconds
Trial: 12716332
Drug: Powered toothbrush
RxNorm normalized name: Pro Clean Spinbrush Powered Toothbrush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powered toothbrush (PTB) with brushing force of 150 g for 30, 60, 120, and 180 seconds
Trial: 12716332
Drug: Powered toothbrush
RxNorm normalized name: Pro Clean Spinbrush Powered Toothbrush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powered toothbrush (PTB) with brushing force of 225 g for 30, 60, 120, and 180 seconds
Trial: 12716332
Drug: Powered toothbrush
RxNorm normalized name: Pro Clean Spinbrush Powered Toothbrush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powered toothbrush (PTB) with brushing force of 300 g for 30, 60, 120, and 180 seconds
Trial: 12716332
Drug: Brushing time
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brushing time of 120 seconds with forces in excess of 150 g
Trial: 10938215
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch (used for the first 35 days)
Trial: 10938215
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch (removed after 35 days)
Trial: 10938215
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch (for females)
Trial: 1345900
Drug: Broxaterol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broxaterol (0.5 mg three times a day for seven days)
Trial: 28777755
Drug: ADS-5102 (amantadine)
RxNorm normalized name: Stahist AD
DrugBank: Chlorcyclizine (DB08936)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ADS-5102 (amantadine) 274 mg once daily at bedtime
Trial: 19849996
Drug: Intradermal trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal trivalent inactivated seasonal influenza vaccine (15 microg of haemagglutinin per strain per 0.1 ml dose)
Trial: 19849996
Drug: Intradermal trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal trivalent inactivated seasonal influenza vaccine
Trial: 19849996
Drug: Conventional intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional intramuscular vaccine
Trial: 15315995
Drug: Fluoxetine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine with CBT (10 to 40 mg/d)
Trial: 15315995
Drug: Fluoxetine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine alone (10 to 40 mg/d)
Trial: 15315995
Drug: Placebo (equivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (equivalent to 10 to 40 mg/d)
Trial: 15315995
Drug: Fluoxetine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine with CBT
Trial: 11699608
Drug: E 5
RxNorm normalized name: Fe 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E 5 mg (intranasal)
Trial: 11699608
Drug: E 10
RxNorm normalized name: RE 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E 10 mg (intranasal)
Trial: 11699608
Drug: E 50
RxNorm normalized name: Fe 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E 50 mg (oral)
Trial: 9814459
Drug: Standardized regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized regimen of calcium supplements and phosphorus binders, no vitamin D derivatives
Trial: 7640329
Drug: m-CPP (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: m-CPP (0.1 mg/kg) in untreated conditions
Trial: 9107154
Drug: Light treatment
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light treatment
Trial: 2752859
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment without preoperative measures
Trial: 593989
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of indomethacin
Trial: 29196479
Drug: Digital cognitive-behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digital cognitive-behavioural therapy for insomnia (CBT-I) for 6 weeks
Trial: 26485217
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (50,000 IU orally once weekly for 8 weeks)
Trial: 26485217
Drug: Placebo (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (oral placebo once weekly for 8 weeks)
Trial: 21741720
Drug: Concurrent re‐irradiation,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent re‐irradiation, fluorouracil and hydroxyurea (R‐RT)
Trial: 2012354
Drug: Ciprofloxacin plus
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin plus loperamide (4 mg first dose, 2 mg for every loose stool, max 16 mg/d)
Trial: 29499208
Drug: Water vapor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water vapor thermal therapy (Rezūm® System)
Trial: 29499208
Drug: Any medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any medical therapy (doxazosin and/or finasteride)
Trial: 19087695
Drug: Yunnan Baiyao
RxNorm normalized name: CAMPHOR (SYNTHETIC) 40.74 mg / MENTHOL 51.84 mg / METHYL SALICYLATE 117.998 mg TOPICAL PATCH [Yunnan Baiyao Pain Relieving]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yunnan Baiyao capsules, orally 4 days before operation once daily and then via nasal feeding tube after operation once a day for 5 days
Trial: 16153398
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg mosapride (3 times daily for 5 days)
Trial: 16153398
Drug: Naloxone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (2 mg administered after morphine)
Trial: 16153398
Drug: Mosapride in
RxNorm normalized name: Product containing mosapride in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mosapride in rats (100 mg/kg orally)
Trial: 1932450
Drug: Selective decontamination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective decontamination with 4 x 100 g polymyxin E, 4 x 80 mg tobramycin and 4 x 500 mg amphotericin B administered through the gastric tube and with an antimicrobial sticky paste in the oropharynx (group I)
Trial: 1932450
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of polymyxin B and 80 mg of gentamicin dissolved in 10 ml of 0.9% saline at 6 h intervals into nose, oropharynx and stomach as well as 300 mg of amphotericin B in the oropharynx only (group II)
Trial: 26434665
Drug: Lantus® insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lantus® insulin glargine (IGlar)
Trial: 21960113
Drug: Truncal/chest/arm advanced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Truncal/chest/arm advanced pneumatic compression therapy
Trial: 2010437
Drug: Aspirin (85‐325
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (85‐325 mg daily up to or within 48 hours of surgery)
Trial: 2010437
Drug: No aspirin
RxNorm normalized name: XS No Aspirin PR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No aspirin (discontinued at least 4 days before surgery)
Trial: 7104563
Drug: Paracetamol/dextropropoxyphene (control)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol/dextropropoxyphene (control)
Trial: 29556866
Drug: AZD5672 (experimental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD5672 (experimental compound)
Trial: 24332324
Drug: Preemptive lornoxicam
RxNorm normalized name: lornoxicam
DrugBank: Lornoxicam (DB06725)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preemptive lornoxicam 8 mg intravenously 25 minutes before surgery
Trial: 17115388
Drug: Immediate-release levodopa
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Immediate-release levodopa (IR LD)
Trial: 17115388
Drug: Controlled-release levodopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release levodopa (not specified if used in this context)
Trial: 15625351
Drug: Divalproex sodium
RxNorm normalized name: Divalproex Sodium
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Divalproex sodium 1000 mg/day
Trial: 12212876
Drug: Warmed local
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warmed local anesthetic solution (37 degrees C)
Trial: 12212876
Drug: Room-temperature local
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Room-temperature local anesthetic solution (21 degrees C)
Trial: 7780131
Drug: rBPI23 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rBPI23 (1 mg/kg)
Trial: 8597874
Drug: Placebo (human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (human serum albumin, 0.2 mg/kg)
Trial: 22686269
Drug: Risk Reduction
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risk Reduction through Family Therapy (RRFT)
Trial: 30253725
Drug: Intensive pharmacist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive pharmacist intervention at the beginning of oral antineoplastic therapy
Trial: 24856027
Drug: Standard fluid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard fluid administration protocol (Control group, n=200)
Trial: 16631046
Drug: Perioperative topical
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Perioperative topical levofloxacin
Trial: 7910321
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (mitomycin, doxorubicin, and fluorouracil)
Trial: 3213065
Drug: Doxium (calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxium (calcium dobesilate) 1000 mg (2 x 1 capsule) daily for 8 weeks (2 weeks preoperatively and 6 weeks postoperatively)
Trial: 30945151
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) 500 mg once daily for 6 months postoperatively
Trial: 28532702
Drug: Trimetazidine 35
RxNorm normalized name: trimetazidine 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine 35 mg twice daily for 72 hours, starting 48 hours before the procedure, in addition to isotonic saline hydration.
Trial: 28532702
Drug: Trimetazidine 35
RxNorm normalized name: trimetazidine 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine 35 mg twice daily for 72 hours, starting 48 hours before the procedure, in conjunction with isotonic saline hydration.
Trial: 27883324
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (50 μg transdermal oestradiol, 5 mg MPA)
Trial: 20671103
Drug: Conventional glucose-containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional glucose-containing dialysis solution (group A)
Trial: 15603207
Drug: Fexofenadine HCl
RxNorm normalized name: fexofenadine HCl
DrugBank: Fexofenadine (DB00950)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fexofenadine HCl 60 mg/pseudoephedrine HCl 120 mg
Trial: 11282902
Drug: Low-dose sibrafiban
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose sibrafiban plus aspirin (LDS+A)
Trial: 11282902
Drug: High-dose sibrafiban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose sibrafiban (HDS)
Trial: 8777774
Drug: Dextromethorphan (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (1.5 mg/kg)
Trial: 6386897
Drug: Folate mouthwash
RxNorm normalized name: folate
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folate mouthwash (5 ml twice daily for 4 weeks, containing 5 mg folate per 5 ml)
Trial: 28419379
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of local anesthetic to a peripheral pain generator (MTrP or other discrete tender point)
Trial: 28419379
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of local anesthetic
Trial: 16796730
Drug: WS 5570
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WS 5570 600 mg/day
Trial: 16796730
Drug: WS 5570
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WS 5570 1200 mg/day
Trial: 11423999
Drug: G-CSF (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF (5 microg/kg/d) after PBPC transplantation at day 1
Trial: 11423999
Drug: No G-CSF
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No G-CSF administration
Trial: 11423999
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of > 5 x 10(6)/kg CD34+ cells
Trial: 11423999
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of ≤ 5 x 10(6)/kg CD34+ cells
Trial: 23422652
Drug: G-CSF administration
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF administration
Trial: 8873964
Drug: Supervised, non-strenuous,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised, non-strenuous, weight-lifting exercise program (performed once a week at the medical facility and twice a week on their own)
Trial: 1099948
Drug: Inhaled atropine
RxNorm normalized name: atropine sulfate Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled atropine sulfate
Trial: 769527
Drug: Spironolactone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (200 mg/day for 2 months)
Trial: 769527
Drug: Propranolol (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (320 mg/day for 2 months)
Trial: 769527
Drug: Combined administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined administration of spironolactone and propranolol at half dosage
Trial: 16813590
Drug: Laparoscopic rectal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic rectal cancer surgery
Trial: 21160307
Drug: Open rectal
RxNorm normalized name: BOTTLE OPENER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open rectal cancer surgery
Trial: 14752411
Drug: 20 ppm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ppm of inhaled nitric oxide
Trial: 14752411
Drug: No additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No additional inhalatory treatment
Trial: 9206771
Drug: Nomegestrol acetate
RxNorm normalized name: nomegestrol acetate
DrugBank: Nomegestrol acetate (DB13981)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Nomegestrol acetate 5 mg daily per os
Trial: 9206771
Drug: Didrogesteron 10
RxNorm normalized name: Didrogesterone
DrugBank: Dydrogesterone (DB00378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Didrogesteron 10 mg twice a day per os
Trial: 8320052
Drug: Multivitamin supplement
RxNorm normalized name: Vi-Daily Multivitamin Supplement Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamin supplement taken daily for 4 months
Trial: 8320052
Drug: Placebo taken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo taken daily for 4 months
Trial: 17209217
Drug: Multivitamin supplement
RxNorm normalized name: Vi-Daily Multivitamin Supplement Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamin supplement
Trial: 29926912
Drug: Levosimendan (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosimendan (0.1 and 0.2 μg/kg/min)
Trial: 29926912
Drug: Milrinone (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milrinone (0.4 and 0.8 μg/kg/min)
Trial: 25816046
Drug: Religiously integrated
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Religiously integrated cognitive behavioral therapy (RCBT)
Trial: 25816046
Drug: Conventional cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional cognitive behavioral therapy (CCBT)
Trial: 27305903
Drug: Increase in
RxNorm normalized name: Incruse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increase in DSE with treatment
Trial: 20665514
Drug: IGIV-C (Gamunex)
RxNorm normalized name: Gamunex
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IGIV-C (Gamunex) administered every 3 weeks for up to 24 weeks
Trial: 20665514
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered every 3 weeks for up to 24 weeks
Trial: 10726441
Drug: Transdermal hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal hormonal therapy with 50 micrograms of ethynilestradiol and 5 mg of MAP
Trial: 7718318
Drug: Melphalan 15
RxNorm normalized name: Melphalan
DrugBank: Melphalan (DB01042)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Melphalan 15 mg/m2 intravenously (i.v.) and prednisone 60 mg/m2 oral days 1‐4 (MP)
Trial: 7718318
Drug: IFN‐alpha (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN‐alpha (5 x 10(6) IU, subcutaneous (S.C.) 3 times per week)
Trial: 1818628
Drug: Therapeutic concept
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic concept including effective motivation; specific details on dosage and duration not available.
Trial: 7445641
Drug: Urografin 76%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urografin 76% with added calcium (22.5 mEq/l)
Trial: 7445641
Drug: Urografin 76%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urografin 76% with added calcium (33.75 mEq/l)
Trial: 25887469
Drug: Epidural injection
RxNorm normalized name: Sufentanil Citrate 50 ug in 1 mL EPIDURAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural injection of glucocorticoids
Trial: 17729399
Drug: Kiwifruit (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kiwifruit (twice daily for 4 weeks)
Trial: 15056829
Drug: Quinapril 10
RxNorm normalized name: quinapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril 10 mg/day
Trial: 12233807
Drug: Leech therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leech therapy (4 leeches applied topically at painful periarticular sites)
Trial: 12233807
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment for pain (excluding nonsteroidal anti-inflammatory drugs)
Trial: 8010369
Drug: Alternating time
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating time schedule of bright light treatment
Trial: 8010369
Drug: Fixed morning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed morning schedule of bright light treatment
Trial: 8010369
Drug: Fixed evening
RxNorm normalized name: Evenity
DrugBank: Romosozumab (DB11866)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fixed evening schedule of bright light treatment
Trial: 2671449
Drug: Nisoldipine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine (2.5 mg once a day, increased to 5-10 mg per day for 12 weeks)
Trial: 25415245
Drug: Antimicrobial photodynamic
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial photodynamic therapy (aPDT) + Scaling and Root Planing (SRP)
Trial: 23233423
Drug: Automated framework
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automated framework for identifying medication overuse
Trial: 18280939
Drug: Sterile saline
RxNorm normalized name: Aqua Care Sterile Saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterile saline solution (Ss)